National
Drug Registry
Report adverse effect
Help
SI
EN
NATIONAL DRUG REGISTRY
Report adverse effect
Help
SI
EN
KANJINTI 150 mg prašek za koncentrat za raztopino za infundiranje
KANJINTI 150 mg prašek za koncentrat za raztopino za infundiranje
Trastuzumab
Add to compare
General
Composition
Packaging
SmPC
Documents
Documents
Informacije o zdravilu
TEST APPLICATION